Anti-ICAM1 抗体 [EPR16608]
Anti-ICAM1 antibody [EPR16608]
- RabMAb
- Recombinant
- 20ul selling size
- 詳細を見る
5
(5 Reviews)
|
(51 Publications)
Anti-ICAM1 antibody [EPR16608] (ab179707) is a rabbit monoclonal antibody detecting ICAM1 in Western Blot, IHC-P. Suitable for Mouse.
- Biophysical QC for unrivalled batch-batch consistency
- Over 40 publications
別名を表示する
CD54, Intercellular adhesion molecule 1, ICAM-1, MALA-2, MyD10, Icam1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ICAM1 antibody [EPR16608] (AB179707)
Immunohistochemical analysis of paraffin-embedded mouse kidney tissue labeling ICAM1 with ab179707 at 1/2000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Positive staining on endothelial cells of mouse kidney is observed [PMID : 17058232].
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ICAM1 antibody [EPR16608] (AB179707)
Immunohistochemical analysis of paraffin-embedded mouse liver tissue labeling ICAM1 with ab179707 at 1/2000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Positive staining on endothelial cells of mouse liver is observed [PMID : 17058232].
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-ICAM1 antibody [EPR16608] (AB179707)
Blocking/Dilution buffer : 5% NFDM/TBST.
The observed molecular weight is consistent with the literature (PMID : 1712683).
All lanes:
Western blot - Anti-ICAM1 antibody [EPR16608] (ab179707) at 1/1000 dilution
Lane 1:
Mouse spleen lysate at 20 µg
Lane 2:
Mouse liver lysate at 20 µg
Lane 3:
Mouse kidney lysate at 20 µg
Lane 4:
bEnd.3 (Mouse brain endothelioma cell line) whole cell lysate at 10 µg
Lane 5:
A20 (Mouse reticulum sarcoma cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 57 kDa
Observed band size: 80-110 kDa
false
Exposure time: 3s
- WB
Supplier Data
Western blot - Anti-ICAM1 antibody [EPR16608] (AB179707)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1/2 : 1 second; Lane 3 : 10 seconds.
The observed molecular weight is consistent with the literature (PMID : 1712683).
All lanes:
Western blot - Anti-ICAM1 antibody [EPR16608] (ab179707) at 1/1000 dilution
Lane 1:
Mouse lung lysate at 20 µg
Lane 2:
RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 20 µg
Lane 3:
WEHI-231 (Mouse lymphoblast B cell lymphoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 57 kDa
Observed band size: 80-110 kDa
false
- IHC
CiteAb
Immunohistochemistry - Anti-ICAM1 antibody [EPR16608] (AB179707)
Immunohistochemistry-immunofluorescence using Anti-ICAM1 antibody [EPR16608], ab179707. Publication image from Bertrand, L. et al., 2019, Nat Commun, 31043599. Legend direct from paper.
Disruption of NVU and inflammatory responses in EcoHIV-infected brains. Mice were infected as in Fig. 1, and analyses were performed 3 weeks post infection. Brain sections were stained for ZO-1 (a), laminin (b), ICAM-1 (c), and P-selectin (d). In a, b, n = 6 mice, 20 microvessels per mice, 2 independent experiments. In c, d, n = 6 mice per group, 10 microvessels per mice, 2 independent experiments. e BBB permeability in mock- and EcoHIV-infected mice as assessed by the sodium fluorescein (NaF) extravasation method; n = 10 per group, 2 independent experiments. Whiskers-box plots represent centerline median, with interquartile range and min-max whiskers. Source data are provided as a Source Data file. **p < 0.01 vs mock; unpaired t test. a–d Scale bars : 40 µm
- IHC
CiteAb
Immunohistochemistry - Anti-ICAM1 antibody [EPR16608] (AB179707)
Immunohistochemistry-immunofluorescence using Anti-ICAM1 antibody [EPR16608], ab179707. Publication image from Bertrand, L. et al., 2019, Nat Commun, 31043599. Legend direct from paper.
EcoHIV diminishes post-ischemic stroke NVU recovery. Mice were infected with EcoHIV and subjected to stroke as in Fig. 1. Brain sections were stained for laminin (a), ICAM-1 (b) and P-selectin (c) 24 h post stroke, and quantified for mean fluorescence index (MFI); n = 6 mice per group, 10 microvessels per mice, 2 independent experiments. d Time course of ICAM1 expression levels as quantified by western blotting in sham and ischemic stroke animals at days 1, 4, 7, and 14 post-stroke both in mock (M) and EcoHIV-infected (E) mice. Representative blots are shown, and quantified results from 5–12 samples per group are illustrated on the bar graphs. e Representative image (left) and quantified results (right) of infiltration of the infarct area by Lys6g immunoreactive cells (neutrophils) at 24 h post-ischemic stroke. The sections were also stained for MAP2 (neurons) and Hoechst (nuclei). Absence of MAP2 staining indicates infarct area. Data quantified from 6 mice per group, 2 independent experiments, 4 fields of view per mice at x20 magnification; Z stack images. Whiskers-box plots represent centerline median, with interquartile range and min-max whiskers. Source data are provided as a Source Data file. **p < 0.01; ***p < 0.001; unpaired t test. a–c Scale bars : 40 µm; e scale bar : 320 µm
- WB
CiteAb
Western blot - Anti-ICAM1 antibody [EPR16608] (AB179707)
Western Blotting using Anti-ICAM1 antibody [EPR16608], ab179707. Publication image from Bertrand, L. et al., 2019, Nat Commun, 31043599. Legend direct from paper.
Effective targeting of EcoHIV diminishes post-ischemic stroke inflammation. Mice were infected, treated with ART-7 and ART-11, and subjected to ischemic stroke as in Fig. 6b, c. mRNA levels of cellular activation markers Iba1 (a) and GFAP (b) 7 days post stroke. Protein expression levels of Iba1 (c), GFAP (d), and ICAM1 (e) were quantified by immunoblotting in sham and ischemic stroke animals at day 14 post-stroke in mock (M) and EcoHIV-infected (E) mice that were treated with ART-7 (E + 7) or ART-11 (E + 11). Representative blots are shown, and quantified results are illustrated on the bar graphs. mRNA levels of anti-inflammatory markers ICAM-5 (f) and FoxP3 (g), and tissue degrading enzymes MMP2 (h) and MMP9 (i) were quantified by RT-qPCR. Impact of therapy on viral DNA genome levels was evaluated in ipsilateral hemisphere (j) and spleen (k); n = 5–16 mice per group, 2 independent experiments. Whiskers-box plots represent centerline median, with interquartile range and min-max whiskers. Other graphs represent data as mean and SEM with individual data points. Source data are provided as a Source Data file. *p < 0.05 or **p < 0.01; one-way ANOVA, followed by Tukey multiple comparison test (a, b and f–k), and unpaired t test (c–e)
false
- WB
CiteAb
Western blot - Anti-ICAM1 antibody [EPR16608] (AB179707)
Western Blotting using Anti-ICAM1 antibody [EPR16608], ab179707. Publication image from Bertrand, L. et al., 2019, Nat Commun, 31043599. Legend direct from paper.
EcoHIV diminishes post-ischemic stroke NVU recovery. Mice were infected with EcoHIV and subjected to stroke as in Fig. 1. Brain sections were stained for laminin (a), ICAM-1 (b) and P-selectin (c) 24 h post stroke, and quantified for mean fluorescence index (MFI); n = 6 mice per group, 10 microvessels per mice, 2 independent experiments. d Time course of ICAM1 expression levels as quantified by western blotting in sham and ischemic stroke animals at days 1, 4, 7, and 14 post-stroke both in mock (M) and EcoHIV-infected (E) mice. Representative blots are shown, and quantified results from 5–12 samples per group are illustrated on the bar graphs. e Representative image (left) and quantified results (right) of infiltration of the infarct area by Lys6g immunoreactive cells (neutrophils) at 24 h post-ischemic stroke. The sections were also stained for MAP2 (neurons) and Hoechst (nuclei). Absence of MAP2 staining indicates infarct area. Data quantified from 6 mice per group, 2 independent experiments, 4 fields of view per mice at x20 magnification; Z stack images. Whiskers-box plots represent centerline median, with interquartile range and min-max whiskers. Source data are provided as a Source Data file. **p < 0.01; ***p < 0.001; unpaired t test. a–c Scale bars : 40 µm; e scale bar : 320 µm
false
関連する標識済み抗体及び組成の異なる製品 (2)
-
Anti-ICAM1 antibody [EPR16608] - Low endotoxin, Azide free
-
Anti-ICAM1 antibody [EPR16608] - BSA and Azide free
Reactivity data
製品の詳細
What is this antibody validated in?
Anti-ICAM1 antibody [EPR16608] (ab179707) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Mouse samples.
What is the molecular weight of ICAM1?
Anti-ICAM1 [EPR16608] (ab179707) specifically detects a band for ICAM1 (UniProt: P13597) at a molecular weight of 58kDa.
Trusted by the scientific community
Anti-ICAM1 [EPR16608] (ab179707) was first used in a scientific publication in 2016 and has been cited over 40 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [EPR16608] also available for your convenience: ab179707, Carrier free - ab222498, Carrier free - ab271933
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (51)
Recent publications for all applications. Explore the full list and refine your search
Journal for immunotherapy of cancer 13: PubMed39805660
2025
Applications
Unspecified application
Species
Unspecified reactive species
Vascular biology (Bristol, England) 6: PubMed38717284
2024
Applications
Unspecified application
Species
Unspecified reactive species
PLoS neglected tropical diseases 18:e0011993 PubMed38408129
2024
Applications
Unspecified application
Species
Unspecified reactive species
Toxics 11: PubMed37888695
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cardiovascular medicine 10:1266276 PubMed37823176
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37445879
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of environmental research and public health 20: PubMed37107767
2023
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:106655 PubMed37168551
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed36835151
2023
Applications
Unspecified application
Species
Unspecified reactive species
PLoS biology 21:e3001989 PubMed36745682
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com